Trial ID 21367 | Maryland Oncology Hematology Trial ID 21367 – Maryland Oncology Hematology

Trial ID 21367

Trial Information

The PATHFINDER 2 Study: Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population

Protocol ID: GRAIL-012

Sponsor: GRAIL, Inc.

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Benign Hematology

Investigator

Taksey MD, Jason

Status

OPEN TO ENROLLMENT

Sponsor

GRAIL, Inc.

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology